Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Median PS Value : $0.00 (As of May. 12, 2024)

Skystar Bio-Pharmaceutical Co Median PS Value Chart

Skystar Bio-Pharmaceutical Co Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Median PS Value		Get a 7-Day Free Trial					7.67	8.43	9.33	5.70	7.06

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Median PS Value	Get a 7-Day Free Trial															-	7.06	-	-	-

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Median PS Value

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skystar Bio-Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Price-to-Median-PS-Value falls into.

Skystar Bio-Pharmaceutical Co Median PS Value Calculation

Skystar Bio-Pharmaceutical Co's Median PS Value for today is calculated as

10-Year Median PS Ratio is 0.
Skystar Bio-Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.092.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skystar Bio-Pharmaceutical Co  (GREY:SKBI) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Skystar Bio-Pharmaceutical Co's Price to Median PS Value for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skystar Bio-Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description